Articles On Botanix Pharmaceuticals (ASX:BOT)

Clinical stage cannabinoid company Botanix Pharmaceuticals (ASX:BOT) has announced that Dr Mark Blaskovich presented antimicrobial data from studies recently conducted with its product candidate BTX 1801 at the American Society for...

The two ASX traded companies BOT and NHS  had updated investors about the latest developments in the market. With a positive YTD return, both stocks have gained momentum over the past few months. Botanix Pharmaceuticals Limited (ASX: BOT) S...

In another “world first” this week, Botanix Pharmaceuticals (ASX: BOT) has revealed its antimicrobial cannabidiol (CBD)-based product BTX 1801 can treat serious skin infections including superbugs. The study using BTX 1801 was carried out i...

In another “world first” this week, Botanix Pharmaceuticals (ASX: BOT) has revealed its antimicrobial cannabidiol (CBD)-based product BTX 1801 can treat serious skin infections including superbugs. The study using BTX 1801 was carried out i...

The Botanix Pharmaceuticals Ltd (ASX: BOT) share price has been a standout performer on the Australian share market on Thursday. In morning trade the clinical stage cannabinoid company’s shares rocketed 25% higher to an all-time high of 17....

Pot stock Botanix (ASX:BOT) says one of its cannabis formulations kills superbugs — in animals and in the lab. Botanix is better known to investors as a biotech developing cannabis-based medications for skin conditions, but it also has a re...

At the start of every trading day, it can be useful to know which stocks are humming out of the gate. Often, the moves are part of the usual market ructions in small caps, but sometimes a big announcement can cause a stock to rocket higher...

Medical dermatology company Botanix Pharmaceuticals (ASX:BOT) has updated investors on the findings of the BTX 1801 antimicrobial study.

Shares in grow-your-own-bone biotech Orthocell (ASX:OCC) are up after it proved, once again, that we live in science fiction times. Today the company said all 10 patients in a dental bone regeneration study had successfully grown enough new...

The market has continued its charge on Wednesday and is trading notably higher this morning. Two companies that are certainly on a high right now are the cannabis companies listed below. Here’s why they are smoking the market today: The Bot...

New results from a “world-first” study by Botanix Pharmaceuticals (ASX: BOT) has identified significant anti-inflammatory and immune modulating effects from using cannabidiol (CBD) to treat skin diseases such as psoriasis. The medical derma...

Two stocks BOT and PM1 are on trading halts, pending their upcoming announcements on ASX. Let us have an overview of the recent developments and the performance of the stocks for these companies. Botanix Pharmaceuticals Limited Strong Devel...

Honey containing THC *might* be able to be exported and imported. The UK is the Next Big Thing in pot, Brexit or no. And 2020 is starting to look like a very hard deadline for a series of big events. There are 30 companies doing, or saying...